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SCIENTIFIC OPINION 
Scientific Opinion on the safety and efficacy of niacin (nicotinic acid and 
nicotinamide) as a feed additive for all animal species based on a dossier 
submitted by Lonza Benelux BV
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The term ‘niacin’ is used as a generic description of nicotinic acid and nicotinamide with pyridine as the basic 
structure. Nicotinic acid and nicotinamide function mainly as precursors of the co-enzymes NAD and NADP. 
Thus,  nicotinamide  has  physiologically  critical  roles  in  mitochondrial  respiration  and  in  the  metabolism  of 
carbohydrates, lipids, and amino acids. Oral administration routes of nicotinic acid and nicotinamide via feed or 
water for drinking were considered bioequivalent. Niacin is safe for the target animals with a margin of safety 
that is at least ten times the requirements and use levels. The FEEDAP Panel assumes that exposure figures for a 
population already include the contribution of edible tissues and products of animals fed niacin-supplemented 
diets. Information on niacin metabolism and the limited data available on retention in edible tissues and products 
indicate that supplemental levels in feeds even far higher than the requirements (1–35 mg/kg feed) are highly 
unlikely to lead the tolerable upper intake level being exceeded. The FEEDAP Panel considers that the use of 
niacin in animal nutrition is not of safety concern for consumers. Nicotinic acid and nicotinamide are not irritant 
to skin, but can cause irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. 
Workers might be exposed to a respirable dust when handling nicotinic acid, which should be regarded as being 
potentially harmful to their health. Nicotinamide is considered to be of no concern for inhalation exposure. The 
use of nicotinic acid and nicotinamide in animal nutrition does not pose a risk to the environment. Nicotinic acid 
and nicotinamide are regarded as effective sources of niacin in animal nutrition. 
© European Food Safety Authority, 2012 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of ‘niacin (nicotinic acid) and niacinamide (nicotinamide)’ as additives to feed and water for 
drinking for all animal species. 
The term ‘niacin’ is used as a generic description of nicotinic acid and nicotinamide (niacinamide) 
with pyridine as the basic structure. Niacin is widely distributed and occurs in large quantities in 
yeasts, brans and food of animal origin. Nicotinic acid and nicotinamide function mainly as precursors 
of  the  co-enzymes  NAD  and  NADP.  Thus,  nicotinamide  has  physiologically  critical  roles  in 
mitochondrial respiration and in the metabolism of carbohydrates, lipids, and amino acids. 
Oral administration routes of nicotinic acid and nicotinamide via feed or water for drinking were 
considered bioequivalent. 
Niacin is safe for the target animals with a margin of safety that is at least ten times the requirements 
and use levels. 
The FEEDAP Panel assumes that exposure figures for a population already include the contribution of 
edible  tissues  and  products  of  animals  fed  niacin-supplemented  diets.  Information  on  niacin 
metabolism and the limited data available on retention in edible tissues and products indicate that 
supplemental levels in feeds even far higher than the requirements (1–35 mg/kg feed) are highly 
unlikely to lead the tolerable upper intake level being exceeded. The FEEDAP Panel considers that 
the use of niacin in animal nutrition is not of safety concern for consumers.  
The FEEDAP Panel considers that nicotinic acid and nicotinamide are not irritant to skin, but they can 
cause irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. Workers 
might be exposed to a respirable dust when handling nicotinic acid, which should be regarded as 
being potentially harmful to their health. Nicotinamide is considered to be of no concern for inhalation 
exposure. 
The use of nicotinic acid and nicotinamide in animal nutrition does not pose a risk to the environment. 
Nicotinic acid and nicotinamide are regarded as effective sources of niacin in animal nutrition. Nicotinic acid and nicotinamide for all animal species 
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BACKGROUND 
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular,  Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7; in addition Article 10(2) of that Regulation also specifies that 
for existing products within the meaning of Ar ticle 10(1), an application shall be submitted in 
accordance with Article 7, at the latest one year before the expiry date of the authorisation given 
pursuant to Directive 70/524/EEC for additives with a limited authorisation period, and within a 
maximum of seven years after the entry into force of this Regulation for additives authorised without 
time limit or pursuant to Directive 82/471/EEC. 
The European Commission received a request from the  company Lonza Benelux BV
5  for  (i)  the 
authorisation of a new use (i.e., use in water for drinking)  and (ii) the re-evaluation of the product 
niacin (nicotinic acid) and niacinamide (nicotinamide),  when used as a feed additive for  all animal 
species (category: nutritional additive; functional group: vitamins, provitamins and chemically well-
defined substances having similar effect) under the conditions mentioned in Table 1. 
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application to the European Food Safety Authority (EFSA) as  an application under Article 4(1) 
(authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re -evaluation 
of an authorised feed additive).  EFSA received directly from the applicant the technical dossier in 
support of this ap plication.
6 According to Article 8 of that Regulation, EFSA, after verifying the 
particulars and documents submitted by the applicant, shall undertake an assessment in order to 
determine whether the feed additive complies with the conditions laid down in A rticle 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  20 July 
2011.
7 
Nicotinic  acid  in  the  form  of  nicotinic  acid  (niacin)   and  nicotinic  acid  amide  (nicotinamide -
niacinamide, NA) has been authorised without time limit under Council Directive 70/524/EEC
8 for its 
use for all animal species as a nutritional additive. 
The Scientific Committee on Food (SCF) expressed an opinion on the tolerable upper intake level of 
nicotinic acid and nicotinamide (niacin)   (EC,  2002). The Panel on  Food Additives and Nutrient 
Sources added to food (ANS) issued an opinion on inositol hexanicotinate (inositol hexaniacinate) as a 
source of niacin (vitamin B3) added for nutritional purposes in food supplements (EFSA, 2009a) and 
an opinion on the inability to assess the safety of niacin-enriched yeast added for nutritional purposes 
as a source of niacin in food supplements and the bioavailability of niacin from this source, based on 
the supporting dossier (EFSA, 2009b). The NDA Panel expressed two opinions on the substantiation 
of several health claims related to niacin pursuant to Article 13(1) of Regulation (EC) No 1924/2006 
(EFSA, 2009c, 2010). The FEEDAP Panel issued an opinion on the safety and efficacy of niacin 
(nicotinamide) as a feed additive for all animal species (EFSA, 2012). 
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of niacin (nicotinic 
acid) and niacinamide (nicotinamide), when used under the conditions described in Table 1. 
                                                       
4   Regulation (EC) 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5   Lonza Benelux BV, Aluminiumstraat 1, 4800 AL Breda, NL. 
6   EFSA Dossier reference: FAD-2010-0112. 
7  A new mandate was received in EFSA in March 2011. 
8  Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. Nicotinic acid and nicotinamide for all animal species 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive  
Niacin (Nicotinic acid) 
Niacinamide (Nicotinamide) 
Registration number/EC No/No 
(if appropriate)  - 
Category of additive  3. Nutritional additives 
Functional group(s) of additive 
A. Vitamins, pro-vitamins and chemically well defined 
substances having a similar effect. 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Niacin (Nicotinic acid)  C6H5NO2  Min. 99.5 % 
European 
Pharmacopoeia 
01/2005: 0459 
Niacinamide (Nicotinamide)  C6H6N2O  Min. 99.0 % 
European 
Pharmacopoeia 
01/2005: 0047 
 
Trade name (if appropriate)  Not appropriate 
Name of the holder of authorisation 
(if appropriate)  Not appropriate 
 
Conditions of use 
Species  or  category  
of animal 
Maximum 
Age 
Minimum content  Maximum 
content  Withdrawal 
period 
(if appropriate) 
Mg or Units of activity or CFU kg
-1 of 
complete feedingstuffs, supplementary feed 
(based on end feed) and in water* 
All animal species 
and categories  -  -  -  - 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for use (if 
appropriate)  Not applicable 
Specific conditions or restrictions for 
handling (if appropriate)  Please refer to MSDS 
Post market monitoring 
(if appropriate)  Not applicable 
Specific conditions for use in 
complementary feedingstuffs or water 
(if appropriate) 
Not applicable 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) 
or food products 
Maximum 
content in tissues 
-  -  -  - Nicotinic acid and nicotinamide for all animal species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  single  company  involved  in  the 
production/distribution of nicotinic acid and nicotinamide. It should be recognised that these data 
cover only a fraction of existing additives containing nicotinic acid and nicotinamide. The application 
is for the active substance and the composition of the additive formulations is not the subject of the 
application. The Panel has sought to use the data provided together with data from other sources to 
deliver an opinion. 
1.  Introduction 
The term ‘niacin’ is used as a generic description of nicotinic acid and nicotinamide (niacinamide) 
with pyridine as the basic structure. Niacin is widely distributed and occurs in large quantities in 
yeasts, brans and food of animal origin. Nicotinic acid and nicotinamide function mainly as precursors 
of  the  co-enzymes  NAD  and  NADP.  Thus,  nicotinamide  has  physiologically  critical  roles  in 
mitochondrial respiration and in the metabolism of carbohydrates, lipids and amino acids. 
Niacin in the form of nicotinic acid (niacin) and nicotinic acid amide (nicotinamide–niacinamide, NA) 
is  included  in  the  European  Union  Register  of  Feed  Additives  pursuant  to  Regulation  (EC)  No 
1831/2003. It is authorised without a time limit in application of Article 9t (b) of Council Directive 
70/524/EEC
9 concerning additives in feedingstuffs (2004/C 50/01) for use in all animal species as a 
nutritional additive. No maximum levels of nicotinic acid in feeds are established in the EU. 
The applicant asks for the re -evaluation of the use of  niacin (nicotinic acid) and niacinamide 
(nicotinamide) as additives to feed for all animal species and categories without restrictions for age, 
(withdrawal) time and content in feedingstuffs. The applicant is also seeking for a new use of  niacin 
(nicotinic acid) and niacinamide (nicotinamide) in water for drinking. 
Niacin  as  nicotinic  acid and  nicotinamide is authorised for use in food ( Regulation  (EC)  No 
1925/2006,
10  amended  by  Regulation  (EC)  No  1 170/2009)
11  and  food  supplements  ( Directive 
2002/46/EC,  Annex  II ),
12  for  addition  for  specific  nutritional  purposes  to  foods  for  particular 
nutritional uses (Regulation (EC) No 953/2009),
13 and for addition to processed cereal -based foods 
and baby foods for i nfants and young children (Directive 2006/125/EC, Annex IV)
14 and to infant 
formulae and follow-on formulae when reconstituted as instructed by the manufacturer (Directive 
2006/141/EC, Annex III).
15 Niacin (as vitamin B3) is also listed as pharmacologically active substance 
in veterinary medicinal products and it is not subject to maximum residue levels when used in food-
producing animals (Commission Regulation (EC) No 37/2010).
16 Nicotinic acid is authorised for the 
treatment of dyslipidaemias (EMEA/H/C/000889).  
                                                       
9  Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. 
10 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404 30.12.2006, p. 26. 
11 Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European 
Parliament and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards 
the lists of vitamin and minerals and their forms that can be added to foods, including food supplements. OJ L 314 
1.12.2009, p. 36. 
12 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183 12.7.2002, p. 51. 
13 Commission Regulation (EC) 953/2009 of 13 October 2009 on substances that may added for specific nutritional purposes 
in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9. 
14 Commission Directive 2006/125 EC of 5 December 2006 on processed cereal-based foods and baby-foods for infants and 
young children. OJ L 339 6.12.2006, p. 16. 
15 Commission Directive 2006/141 EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC. OJ L 401 30.12.2006, p. 1. 
16 Commission Regulation (EU) 37/2010 of 22 December 2009 on pharmacologically active substances and their 
classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1. Nicotinic acid and nicotinamide for all animal species 
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Nicotinic acid and nicotinamide are described in the European Pharmacopeia (PhEur) in Monographs 
(MG) 0459 and 0047, respectively. 
2.  Characterisation 
2.1.  Characterisation of the active substance 
2.1.1.  Nicotinic acid 
Nicotinic acid (IUPAC name: 3-pyridine carboxylic acid, synonyms: niacin, vitamin B3, vitamin PP) is 
identified by the CAS (Chemical Abstracts Service)  number 59-67-6 and the EINECS (European 
Inventory of Existing Chemical Substances) number 200-441-0. The structural formula of nicotinic 
acid is shown in Figure 1. 
       
Figure 1:  Structural formula of nicotinic acid 
The molecular formula of nicotinic acid is C6H5NO2 and its molecular weight is 123.11. It has a pKa of 
4.85, a log POW of -0.59, a melting point of 234–237 °C, a flash point of 193 °C, shows a bulk density 
of approximately 0.65–0.75 g/cm
3, and a vapour pressure of 0.1 mbar (at 50 °C). It is soluble in water 
(15 g/L at 20 °C and 150 g/L at 100 °C) and in ethanol (12.5 g/L at 20 °C). 
Nicotinic acid is a white odourless powder or granules. Nicotinic acid is described in the European 
Pharmacopoeia (PhEur 7.0, 0459) with a purity of 99.5–100.5 % pyridine-3-carboxylic acid in dried 
substance,  less than  0.5  %  related  substances,  <  200  mg  chlorides/kg,  <  10  mg  heavy  metals/kg 
(calculated as Pb), ≤ 1 % loss on drying and ≤ 0.1 % sulphated ash. The additive contains at least 99.5 
% of the active substance by specification. Analysis of five batches of the product showed an average 
(± SD) content of niacin of 99.9 ± 0.1 %,
17 in compliance with PhEur  0459 and a water content  of 
0.048 ± 0.004 %. 
Total related impurities  (determined by HPLC in five batches)  were below 0.1 % ,  chloride  and 
sulphated ash (determined in three batches)  were below 0.02 % and below 0.05 %, respectively.
 All 
three parameters comply with the thresholds of PhEur. For impurities the following mean values from 
three batches were provided: dioxins < 0.03 ng WHO-PCDD/F-TEQ/kg, sum of dioxin and dioxin like 
PCBs < 1.0 ng WHO-PCDD/F-PCB-TEQ/kg, lead < 0.05 mg/kg, arsenic < 0.1 mg/kg, cadmium < 
0.01 mg/kg and mercury < 0.005 mg/kg, fluorine < 10 mg/kg, aflatoxin B1 < 0.01 µg/kg, hydrocyanic 
acid < 10 mg/kg.
18 The product complies with the Directive 2002/32/EC.
19 
The particle size distribution has been determined  in ten batches of nicotinic acid by sieving. The 
particle fractions (w/w) below 32, 63 and 100 µm were 2 %, 2 % and 4 %, respectively. An additional 
batch was analysed for particle size distribution by laser diffraction analysis. The fraction s below 10 
and 50 µm were 2.1 % and 4.6 % (v/v), respectively. The substance showed a dusting potential of 1.5 
g/m
3. Dust generated from the Stauber-Heubach test revealed an amount of 48 % of particles < 10 
µm.
20 
                                                       
17 Technical dossier/Section II. 
18 Technical dossier/Section II and Supplementary information April 2012. 
19 Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal 
feed. OJ L 140, 30.5.2002, p. 10. 
20 Technical dossier/Supplementary information April 2012/Annex II.1.03 and II.1.04. Nicotinic acid and nicotinamide for all animal species 
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Niacin is obtained by reacting 5-ethyl-2-methylpyridine with nitric acid. The process is backintegrated 
to Light Virgin Naphta / Liquid Petroleum Gas (LVN/LPG), water and air. The applicant provided a 
flow-chart of the synthetic process. Control measures are in place. 
2.1.2.  Nicotinamide 
Nicotinamide  (IUPAC  name:  3-pyridinecarboxamide,  synonyms:  nicotinamide,  vitamin  B3)  is 
identified by the CAS number 98-92-0 and the EINECS number 202-713-4. The structural formula of 
nicotinamide is shown in Figure 2. 
       
Figure 2:  Structural formula of nicotinamide 
The molecular formula of nicotinamide is C6H6N2O and its molecular weight is 122.11. It has a pKa of 
3.35–3.65, a log POW of -0.38, a melting point of 128–131 °C, a boiling point of 224 °C, a flash point 
> 150°C, and shows a bulk density of approximately 0.50–0.70 g/cm
3. It is soluble in water (691 g/L at 
20 °C) and ethanol (660 g/L at 20 °C).  
Nicotinamide  is  a  white  or  almost  white  odourless  crystalline  powder  or  colourless  crystals. 
Nicotinamide is described in the European Pharmacopoeia (PhEur 7.0, 0047) with a purity of 99.0–
101.0 %  pyridine-3-carboxamide  in  dried  substance,  less than  0.25  %  related  substances,  loss on 
drying < 0.5 %, sulphated ash < 0.1 % and heavy metals (calculated as Pb) < 30 mg/kg. The additive 
contains at least 99.0 % of niacinamide  by specification.  Analysis of five batches of the product 
showed an average (± SD) niacinamide content of 99.8 ± 0.2 %,
21 in compliance with PhEur 0047. 
Total related impurities were below 0.1 % (determined by HPLC in five batches), impurity A (niacin) 
< 0.04 %, impurity B (3 -cyanopyridine) < 0.03 % a nd impurity C (other impurities) < 0.05 %, 
sulphated ash (three batches) < 0.05 %, all parameters complying with the thresholds of PhEur. Data 
for residual solvents indicate that VICH  (International Cooperation on Harmonisation of Technical 
Requirements for Registration of Veterinary Medicinal Products) thresholds for solvents of class 2 and 
3 are not exceeded. For other impurities, the following mean values from three batches were provided: 
dioxins < 0.03 ng WHO-PCDD/F-TEQ/kg, sum of  dioxin and dioxin like  PCBs < 1.0 ng WHO-
PCDD/F-PCB-TEQ/kg, lead was <  0.05 mg/kg, arsenic < 0.1 mg/kg, cadmium < 0.01 mg/kg and 
mercury < 0.005 mg/kg, fluorine < 10 mg/kg, aflatoxin B1 < 0.01 µg/kg, hydrocyanic acid <10 mg/kg.
 
22 The product complies with the Directive 2002/32/EC.
23 
The particle size distribution has been determined in 10 batches of nicotinamide. The particle fractions 
below 32, 63 and 100 µm were 2.6 %, 3.5 % and 15 %  (w/w), respectively. An additional batch was 
analysed for particle size distribution by laser diffraction analysis. The fractions below 10 and 50 µm 
were 0.7 % and 2.9 % (v/v), respectively. The results of a Stauber-Heubach test for dusting potential 
showed that the product did not produce any measurable dust following shaking.
24  
Nicotinamide is synthesised starting from 3-picoline, which is converted in a catalytic gas reaction 
(ammoxidation reaction) into 3-cyanopyridine. 3-Cyanopyridine is further hydrolysed to nicotinamide 
in the presence of an immobilized biocatalyst. The applicant provided a fl ow-chart of the synthetic 
process. Control measures are in place. 
                                                       
21 Technical dossier/Section II. 
22 Technical dossier/Section II and Supplementary information April 2012. 
23 OJ L 140, 30.5.2002, p. 10. 
24 Technical dossier/Supplementary information April 2012/Annex II.1.05 and II.1.06. Nicotinic acid and nicotinamide for all animal species 
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2.2.  Stability and homogeneity 
Nicotinic acid and nicotinamide are very stable in air and to heat, light, acids and alkalis.  
2.2.1.  Shelf-life of the additives 
Nicotinic  acid  and  nicotinamide  (three  batches  each,  stored  in  the  unopened  container)  were 
demonstrated to have a shelf-life of 36 months at 25  C. Shelf-life of nicotinic acid and nicotinamide 
(three batches each) under accelerated conditions (40 °C) was 12 and 24 months, respectively.
25 
2.2.2.  Stability of the additive when added to premixtures, feed and water for drinking 
The applicant provided information on the stability of nicotinic acid and nicotinamide (one batch each) 
in a premixture consisting of vitamins, trace elements and choline chloride. After six months storage at 
25°C no degradation of either nicotinic acid or nicotinamide was observed.
25 
The stability of nicotinic acid and nicotinamide was tested in formulated pig feed (two batches) during 
storage for a period of three months. The stability was not influenced by feed processing and storage 
of mash and pelleted feed for three months.
26 
The  stability  of  nicotinic  acid  and  nicotinamide  (one  batch  each)  was  investigated  in  water  for 
drinking in the dark at 25 °C. Both substances (40 mg/L) appear stable for 48 h.
26 
2.2.3.  Homogeneity 
Two batches of feed were supplemented with either nicotinic acid or nicotinamide. From each sample 
ten subsamples were taken and analysed for the active substance. The coefficient of variation (CV) for 
nicotinic acid was 3.7 % (110 mg/kg) and 4.8 % (90 mg/kg feed) and for nicotinamide 4.0 % (20 
mg/kg  feed)  and  6.9  %  (55  mg/kg  feed).  The  data  demonstrate  the  ability  of  nicotinic  acid  and 
nicotinamide to homogeneously distribute in feed.  
Considering the solubility of nicotinic acid and nicotinamide in water, homogeneity studies are not 
necessary. 
2.3.  Physico-chemical incompatibilities in feed 
No physico-chemical incompatibilities or interactions have been reported between nicotinic acid and 
nicotinamide and feed materials, carriers, other approved additives or medicinal products when the 
additive was added to premixtures and feed. 
2.4.  Conditions of use 
Niacin in the form of nicotinic acid and nicotinamide is intended for use via feed and water for 
drinking in all animal species and categories without a maximum content and a withdrawal period. If 
used in water for drinking the niacin concentration is recommended to amount to half of that routinely 
used in complete feed. 
2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of niacin (nicotinic 
acid) and niacinamide (nicotinamide) in animal feed. The Executive Summary of the EURL report can 
be found in the Appendix.  
                                                       
25 Technical dossier/Section II. 
26 Technical dossier/Section II/Annex II.6.07 and Supplementary Information April 2012. Nicotinic acid and nicotinamide for all animal species 
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3.  Safety 
According to Regulation (EC) No 429/2008, tolerance, metabolism and residue, and toxicological 
(concerning  consumer  safety)  studies  are  not  required  for  vitamins,  pro-vitamins  and  chemically 
defined  substances  having  similar  effects  which  are  already  authorised  as  feed  additives  under 
Directive 70/524/EEC and which do not have the potential to accumulate, which FEEDAP considers is 
the case for niacin. 
3.1.  Safety for the target species  
The requirements for available niacin are in the range 12.5–20 mg/kg for piglets (3–20 kg bw), 7–
1 mg/kg for grower/finisher pigs and 10 mg/kg diet for gestating/lactating sows (NRC, 1998). Laying 
hens  and  chickens  for  fattening  require  about  8.3–12.5  and  25–35 mg/kg  niacin  in  their  diet, 
respectively (NRC, 1994). For growing and adult dogs, 13.6 mg niacin/kg dry matter (DM) appears to 
be adequate, and for kittens and adult cats about 32 mg/kg DM (NRC, 2006). Deficiencies of niacin 
are unlikely to occur under the present feeding practices. 
Vitamin supplementation of commercial compound feed is mostly oriented towards recommended 
allowances in the range of 8–20 mg/kg for pigs, 25–100 mg/kg for poultry, 60–160 mg/kg for fish and 
20–60 mg/kg feed for pets (AWT, 2002). A survey of vitamin supplementation of commercial feeds 
for pigs and poultry in Europe (Belgium, Denmark, Germany, Italy, Netherlands, Portugal, Spain, 
United Kingdom) identified a range of 0–100 mg niacin/kg as commercial use levels (Gropp, 1994). A 
range for piglets and pigs of 10–40 mg niacin/kg feed was reported by Whittemore et al. (2002). 
The  data  on  the  toxicity  of  niacin  (nicotinic  acid  and  nicotinamide)  are  partially  inconsistent.  In 
finishing pigs the addition of 550 mg niacin per kilogram diet appeared to reduce feed intake and 
weight gain when compared with lower additions; concentrations up to 110 mg niacin/kg feed showed 
no  adverse  effect  on  performance  and  carcass  characteristics  (Real  et  al.,  2002).  Experiments  in 
chickens fed 1 000–20 000 mg/kg in standard chicken diets indicate that high levels of supplemental 
niacin (10 000 mg/kg and above) resulted in decreased tibia weights and bone strength in chicks, 
decreases in tibia dimensions with no change in mineral content of the tibiae, and susceptibility to 
fracture (Johnson et al., 1992, 1995). It seems that nicotinic acid is better tolerated than nicotinamide, 
since 5 000 and 10 000 mg/kg nicotinamide caused a slight and marked growth depression, whereas 
20 000 mg/kg of dietary nicotinic acid did not affect growth in chickens (Baker et al., 1976). 
According to McDowell (2000) and NRC (1987) non-ruminant species evidently tolerate oral niacin 
exposures of at least 10–20 times their normal requirements. It is supposed that a level of 350 mg 
nicotinamide/kg bw and around 1 400 mg nicotinic acid/kg  bw  may be safe  for chronic exposure 
(NRC, 1987). 
3.1.1.  Conclusions on the safety of niacin in target species 
Niacin is safe for the target animals with a margin of safety that is at least ten times the requirements 
and use levels. 
3.2.  Safety for the consumer 
3.2.1.  Absorption, distribution, metabolism and excretion of niacin 
In nature nicotinamide is primarily found in animal tissues (as NAD or NADP), whereas nicotinic acid 
is present in plants. Nicotinic acid and nicotinamide mainly occur in bound forms. In grains, nicotinic 
acid is bound to macromolecules which are contained in cellulose or hemicellulose (Mason et al., 
1973). Accordingly, the niacin in yellow corn, oats, wheat and grain sorghum is evidently largely 
unavailable to young pigs, whereas the availability of niacin in soybean meal is high, at least for 
chicks (Luce et al., 1966; Harmon et al., 1969, 1970; Yen et al., 1977; NRC, 1998). Nicotinamide can 
also be synthesised in target animals (except the cat) from tryptophan; however, the efficacy of this 
route is low. Nicotinic acid and nicotinamide for all animal species 
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Free nicotinic acid and nicotinamide are readily absorbed from the stomach and the small intestine by 
passive  diffusion  or  by  a  Na
+-dependent  carrier-mediated  facilitated  diffusion.  However,  at 
pharmacological doses the passive diffusion predominates. Once absorbed into the intestinal mucosa, 
nicotinic acid is converted to nicotinamide via nicotinic acid mononucleotide to form the nicotinic acid 
analogue  of  NAD  and  subsequently  NAD  and  finally  enzymatic  cleavage  takes  place  to  form 
nicotinamide. The intestinal mucosa and liver are rich in niacin conversion enzymes, such as NAD 
glycohydrolase, which releases nicotinamide from NAD. Nicotinamide, the predominant circulating 
form  of  the  vitamin,  is  transported  to tissues  for  the  synthesis  of  NAD  or  NADP.  The  principal 
excretory product is the methylated, water-soluble metabolite N
1-methyl-nicotinamide or some of its 
oxidation products (e.g. Huff and Perlzweig, 1943, 1945; Knox and Grossman, 1946; Perlzweig et al., 
1950; Reddi and Kodicek, 1953; Chang and Johnson, 1959, 1961; Shibata and Matsuo, 1989a, b, 
1990; Shibata et al., 1990). A detailed description of the absorption and metabolism of nicotinic acid 
and nicotinamide can be found in McDowell (2000) and SCF assessment (EC, 2002). 
Based on a range of measurements, niacin tissue levels are taken to be 50–74 mg/kg meat, about 140–
180 mg/kg liver, 0.8 mg/kg fresh egg, 0.46–0.87 mg/kg milk and 47–65 mg/kg fish flesh (Leeson and 
Caston, 2003; Niehoff et al., 2009; CIV-INRA, 2010; USDA National Nutrient Database). 
Although niacin is generally considered as being rapidly eliminated, without significant potential for 
tissue retention above physiological levels, a few studies show increased deposition after feeding high 
levels to laying hens (about +65 % in eggs) and after duodenal administration (about +75 % in milk) 
(Wagner et al., 1997; Leeson and Caston, 2003). However, another study found a correlation between 
high oral concentrations and lower milk niacin concentration (Nilson et al., 1967). 
3.2.2.  Toxicological studies 
The SCF (EC, 2002) carried out a comprehensive overview of the toxicological profile of nicotinic 
acid  and  nicotinamide  including  data  and  effects  in  humans  and  animals.  Genotoxicity  tests  on 
nicotinic acid and nicotinamide gave negative results. Most of these studies in humans considered the 
known  vasodilatory  effects,  gastrointestinal  effects,  hepatotoxicity  and  glucose  intolerance.  There 
were no reliable multigeneration studies of reproductive toxicity, but a rat developmental study on 
nicotinic acid showed no teratogenicity at 1 000 mg/kg bw per day and a NOAEL (no observable 
adverse effect level) for maternal toxicity and fetotoxicity of 200 mg/kg bw per day (OECD SIDS, 
2002). A 4-week rat feeding study with nicotinamide showed increased liver weight, centrilobular 
hepatocellular  hypertrophy  with  (in  females)  extramedullary  haematopoiesis  in  the  spleen  at 
1 000 mg/kg bw per day with a NOAEL of 215 mg/kg bw per day (OECD SIDS, 2002). 
3.2.3.  Tolerable upper intake level (UL) 
Because  of  the  difference  in  adverse effect  profiles,  different  upper levels  have  been  defined for 
nicotinic acid and nicotinamide. 
The SCF (EC, 2002) defined a UL for nicotinic acid of 10 mg/day in adults, based on the available 
data indicating facial flushing at 30 mg/day, using an uncertainty factor of 3 to allow for the fact that a 
slight effect was reported, and that the study was performed in a small number of subjects, but taking 
into account the steep dose–response relationship. The EVM (2003) identified a guidance level (GL) 
of 17 mg/day based on a lowest observed effect level (LOEL) for facial flushing of 50 mg/day. 
Nicotinamide does not produce the above-mentioned flushing response The UL for nicotinamide is 
established at 12.5 mg/kg bw per day for adults. This was derived from evidence of no adverse effect 
at doses up to 25 mg/kg bw per day in prolonged studies in diabetic subjects. An uncertainty factor of 
2 was applied (EC, 2002). The EVM (2003) identified a GL of 560 mg/day. 
Owing to the absence of data, the UL for nicotinic acid should not be applied to pregnant and lactating 
women (EC, 2002); the GL for nicotinamide should not be applied to pregnant women (EVM, 2003). Nicotinic acid and nicotinamide for all animal species 
 
EFSA Journal 2012;10(7):2788  12 
3.2.4.  Consumer exposure 
The most important sources of nicotinamide (in form of NAD and NADP) are foods of animal origin 
(liver, meat and fish flesh, eggs and milk listed in a decreasing order; see section 3.2.1). 
According to the SCF opinion (EC, 2002), the background intake of niacin equivalents was in the 
range of 11.6 (Germany) to 40.9 (UK) mg/person per day; most of the 97.5th percentile values were in 
the range of 20.5 (Germany) to 67.4 (UK) mg/person per day, showing no risk of exceeding the UL 
for nicotinamide from food sources.  
Assuming that exposure data are derived mostly from foods of animal origin, the population exposure 
provides a sufficient margin of safety (8 to 13) compared with the UL for nicotinamide. 
3.2.5.  Conclusions on consumer safety 
Since niacin supplementation to feedingstuffs of animals is in widespread routine use, the FEEDAP 
Panel assumes that above-mentioned population exposure figures already include the contribution of 
edible tissues and products of animals fed niacin-supplemented diets. 
The information on niacin metabolism and the limited data on retention in edible tissues and products 
indicate that even supplemental levels in feeds far higher than the requirements (1–35 mg/kg feed) are 
highly unlikely to cause any concern about consumers’ exposure exceeding the UL. 
The FEEDAP Panel considers that the use of niacin in animal nutrition is not of safety concern for 
consumers. 
3.3.  Safety for the user 
3.3.1.  Effects on the respiratory system 
Information on particle size distribution and dusting potential (see Sections 2.1.1 and 2.1.2) indicates 
that the nicotinic acid under assessment has the potential to form dust that contains a large proportion 
of  particles  of  respirable  size.  Inhalatory  toxicity  studies  were  not  available.  Consequently,  the 
FEEDAP Panel concludes that inhalation exposure from handling nicotinic acid could be hazardous. 
Nicotinamide  did  not  produce  any  measurable  dust  during  Stauber-Heubach  test  and  is  therefore 
considered to be of no concern for inhalation exposure. 
3.3.2.  Effects on the eyes and skin 
The acute dermal toxicity of nicotinic acid in rats and of nicotinamide in rabbits was low, with an LD50 
greater than 2 000 mg/kg (in both cases) when tested in accordance with OECD Guideline 402.
27 
Nicotinic acid and nicotinamide were not irritant to the skin of rabbits when tested according to OECD 
Guideline 404.
28 They did however cause moderate (for nicotinic acid) or  moderate to severe (for 
nicotinamide) eye irritation when tested in rabbits in accordance with OECD Guideline 405.
29 
Nicotinic acid was ‘not sensitizing’ when tested in a guinea-pig maximisation test in accordance with 
OECD Guideline 406.
30 
The skin sensitisation potential of nicotinamide was tested in guinea-pigs in two studies.
31 A Buehler 
test gave a negative result, but used a group size (five animals of each sex in the treatment group and 
                                                       
27 Technical dossier/Section III/References III.3.01 and III.3.02. 
28 Technical dossier/Section III/ References III.3.04, III.3.03 and III.3.05. 
29 Technical dossier/Section III/ References III.3.06, III.3.07 and III.3.08. 
30 Technical dossier/Section III/ References III.3.09. 
31 Technical dossier/Section III/ References III.3.10 and III.3.11. Nicotinic acid and nicotinamide for all animal species 
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two males and three females as controls) that was too small to be compliant with OECD Guideline 
406. A maximisation test that complied with OECD Guideline 406 showed a positive erythema score 
in 4 animals at 24 h post challenge and in 3 animals at 48 h, out of a group of 20 animals, but the 
OECD (Organisation for Economic Cooperation and Development) SIDS Initial Assessment Report 
(OECD,  2002)  interpreted  this as  a  negative  result.  In  addition,  a  survey  of  50 000  patients  at a 
German dermatological hospital found no cases of skin sensitisation to nicotinamide (OECD, 2002, 
Ref. 116). The FEEDAP concluded that exposure of workers to nicotinic acid and/or nicotinamide is 
unlikely to cause skin sensitisation. 
3.3.3.  Conclusions on user safety 
In conclusion, the FEEDAP Panel considers nicotinic acid and nicotinamide are not irritant to skin, but 
can cause irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. 
Workers might be exposed to a respirable dust when handling nicotinic acid, which should be regarded 
as  being  potentially  harmful  to  their  health.  Nicotinamide  is  considered  to  be  of  no  concern  for 
inhalation exposure. 
3.4.  Safety for the environment 
Niacin occurs widely in nature. Free nicotinic acid (and nicotinamide) is present in nature in only 
small  amounts.  Nicotinic  acid  is  mainly  bound  to  macromolecules  such  as  polysaccharides  and 
peptides or glycopeptides in plants (see, for example, Mason et al., 1971, 1973), whereas nicotinamide 
is  usually  a  component  of  NAD(P)  in  all  animals.  Its  use  in  animal  nutrition  is  not  expected  to 
substantially increase the concentration in the environment. Therefore, the use of niacin in animal 
nutrition is not expected to pose a risk to the environment. 
4.  Efficacy 
According  to  Regulation  (EC)  No  429/2008,  efficacy  studies  are  not  required  for  vitamins,  pro-
vitamins and chemically well-defined substances having similar effects which are already authorised 
as feed additives. 
Owing to the long history of use and its established nutritional role in domestic animals, nicotinic acid 
and nicotinamide are regarded as effective sources of niacin, both having the same potency (Baker et 
al.,  1976).  Niacin  has  been  globally  used  in  animal  nutrition  for  decades.  Data  on  requirements, 
allowances and recommendations for feed supplementation are easily accessible as standard literature 
for animal nutrition experts. All data available in the public literature demonstrate that nicotininc acid 
and nicotinamide when fed to animals are efficacious sources of niacin (see, for example, Da Silva et 
al., 1952; Baker et al., 1976; Yen et al., 1978; Copelin et al., 1980; Waldroup et al., 1985; Harms et al., 
1988; Oduho and Baker, 1993; Real et al., 2002; Ivers and Veum, 2012). 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
32  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Oral  administration  routes  of  nicotinic  acid  and  nicotinamide  via  feed  or  water  for  drinking  are 
considered as bioequivalent. 
                                                       
32 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Nicotinic acid and nicotinamide for all animal species 
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Niacin is safe for the target animals with a margin of safety that is at least ten times the requirements 
and use levels. 
The information on niacin metabolism and the limited data on retention in edible tissues and products 
indicate that even supplemental levels in feeds far higher than the requirements are highly unlikely to 
lead to the UL being exceeded. The FEEDAP Panel considers that the use of niacin in animal nutrition 
is not of safety concern for consumers.  
The FEEDAP Panel considers nicotinic acid and nicotinamide are not irritant to skin, but can cause 
irritancy to eyes and mucous membranes. They are unlikely to cause skin sensitisation. Workers might 
be exposed to a respirable dust when handling nicotinic acid, which should be regarded as being 
potentially harmful to their health. Nicotinamide is considered to be of no concern for inhalation 
exposure. 
The use of nicotinic acid and nicotinamide in animal nutrition does not pose a risk to the environment. 
Nicotinic acid and nicotinamide are regarded as effective sources of niacin in animal nutrition.  
RECOMMENDATION 
The FEEDAP Panel proposes to use the specifications for nicotinic acid and nicotinamide according to 
PhEur  (MG  0459  and  0047)  considering  purity,  substance related  impurities  and  other impurities 
(sulphated ash). 
DOCUMENTATION PROVIDED TO EFSA 
1.  Niacin  (nicotinic  acid)  and  niacinamide  (nicotinamide)  for  all  animal  species.  October  2010. 
Submitted by Lonza Benelux BV. 
2.  Niacin  (nicotinic  acid)  and  niacinamide  (nicotinamide)  for  all  animal  species.  Supplementary 
information. April 2012. Submitted by Lonza Benelux BV  
3.  Evaluation report of the European Union Reference Laboratory for Feed Additives on the methods 
of analysis for nicotinic acid and nicotinamide. 
4.  Comments from Member States received through the ScienceNet. 
REFERENCES 
AWT  (Arbeitsgemeinschaft  für  Wirkstoffe  in  der  Tierernährung  e.V.),  2002.  Vitamins  in  animal 
nutrition, Agrimedia GmbH, ISBN 3-86037-167-3. 
Baker DH, Yen TJ, Jensen AH and Teeter RG, 1976.  Niacin activity in niacinamide and coffee. 
Nutrition Reports International, 14, 115–120. 
Chang  ML  and  Johnson  BS,  1959.  N-methyl-4-pyridone-5-carboxamide,  a  new  major  normal 
metabolite of nicotinic acid in rat urine. The Journal of Biological Chemistry, 234, 1817–1821. 
Chang ML and Johnson BS, 1961. N-Methyl-4-pyridone-5-carboxamide as a metabolite of nicotinic 
acid in man and monkey. The Journal of Biological Chemistry, 236, 2096–2098. 
CIV-INRA  (Center  d’Information  des  Viandes-Institut  National  de  la  Recherche  Agronomique), 
2010.  Valeur  nutritionelle  des  viandes.  Available  from  http://www.lessentieldesviandes-
pro.org/pdf/PDF-tous%20morceaux.pdf 
Copelin JL, Monegue H and Combs GE, 1980. Niacin levels in growing-ﬁnishing swine diets. Journal 
of Animal Science, 51 (Suppl. 1): 190 (Abstract). Nicotinic acid and nicotinamide for all animal species 
 
EFSA Journal 2012;10(7):2788  15 
Da  Silva  AC,  Fried  S  and  De  Angelis  RC,  1952.  The  domestic  cat  as  a  laboratory  animal  for 
experimental  nutrition  studies.  III.  Niacin  requirements  and  tryptophan  metabolism.  Journal  of 
Nutrition, 46, 399–409. 
EC  (European  Commission),  2002.  Opinion  of  the  Scientific  Committee  on  Food  on  the  Upper 
Tolerable  Intake  of  nicotinic  acid  and  nicotinamide  (niacin).  Available  from 
http://ec.europa.eu/food/fs/sc/scf/out80j_en.pdf 
EFSA Panel on Food Additive and Nutrient Sources added to food (ANS), 2009a. Scientific Opinion 
on inositol hexanicotinate (inositol hexaniacinate) as a source of niacin (vitamin B3) added for 
nutritional purposes in food supplements. The EFSA Journal, 949, 1–20. 
EFSA Panel on Food Additive and Nutrient Sources added to food (ANS), 2009b. Scientific Opinion 
on the inability to assess the safety of niacin-enriched yeast for nutritional purposes as a source of 
niacin  in  food  supplements  and  the  bioavailability  of  niacin  from  this  source,  based  on  the 
supporting dossier. The EFSA Journal, 1124, 1–6. 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009c. Scientific Opinion on the 
substantiation of health claims related to niacin and energy-yielding metabolism (ID 43, 49, 54), 
function of the nervous system (ID 44, 53), maintenance of the skin and mucous membranes (ID 
45,  48,  50,  52),  maintenance  of  normal  LDL-cholesterol,  HDL  cholesterol  and  triglyceride 
concentrations (ID 46), maintenance of bone (ID 50), maintenance of teeth (ID 50), maintenance of 
hair (ID 50, 2875) and maintenance of nails (ID 50, 2875) pursuant to Article 13(1) of Regulation 
(EC) No 1924/2006. EFSA Journal, 7(9):1224, 22 pp. 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010. Scientific opinion on the 
substantiation of health claims related to niacin and reduction of tiredness and fatigue (ID 47), 
contribution to normal energy-yielding metabolism (ID 51), contribution to normal psychological 
functions (ID 55), maintenance of normal blood flow (ID 211), and maintenance of normal skin 
and mucous membranes (ID 4700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. 
The EFSA Journal, 8(10): 1757, 17 pp. 
EFSA  Panel  on  Additives  and  Products  or  Substances  used  in  Animal  Feed  (FEEDAP),  2012. 
Scientific  Opinion  on  the  safety  and  efficacy  of  niacin (nicotinamide)  as  feed  additive  for all 
animal species based on a dossier submitted by Agrinutrition BV. EFSA Journal, 10(6):2731, 18pp. 
European  Pharmacopeia  (PhEur),  2010.  Nicotinic  acid,  Monograph  (MG)  0459.  7th  Edition. 
Strasbourg, France. Council of Europe (COE)—European Directorate for the Quality of Medicines. 
European  Pharmacopoeia  (PhEur),  2010.  Nicotinamide,  Monograph  (MG)  0047.  7th  Edition. 
Strasbourg, France. Council of Europe (COE)—European Directorate for the Quality of Medicines. 
EVM  (Expert  Group  on  Vitamins  and  Mineral),  2003.  Niacin  (nicotinic  acid  and  nicotinamide). 
Available from http://www.food.gov.uk/multimedia/pdfs/evm_niacin.pdf 
Gropp JM, 1994. Vitamin Fortification Levels in European Commercial Poultry and Swine Diets. 
Proceedings of the Arkansas Nutrition Conference, Fayetteville, Arkansas, 105–134. 
Harmon BG, Becker DE, Jensen AH and Baker DH, 1969. Nicotinic acid–tryptophan relationship in 
the nutrition of the weanling pig. Journal of Animal Science, 28, 848–852. 
Harmon BG, Becker DE, Jensen AH and Baker DH, 1970. Nicotinic acid–tryptophan nutrition and 
immunologic implications in young swine. Journal of Animal Science, 31, 339–342. 
Harms RH, Ruiz N, Buresh RE, Wilson HR, 1988. Effect of niacin supplementation of a corn-soybean 
meal diet on performance of turkey breeder hens. Poultry Science, 67, 336–338. 
Huff JW and Perlzweig WA, 1943. N -methylnicotinamide, a metabolite of nicotinic acid in urine. The 
Journal of Biological Chemistry, 150, 395–400. 
Huff  JW  and  Perlzweig  WA,  1945.  The  fate  of  N1-methylnicotinamide  in  man.  The  Journal  of 
Biological Chemistry, 161, 417–418. Nicotinic acid and nicotinamide for all animal species 
 
EFSA Journal 2012;10(7):2788  16 
Ivers DJ and Veum TL, 2012. Effect of graded levels of niacin supplementation of a semipurified diet 
on energy and nitrogen balance, growth performance, diarrhea occurrence, and niacin metabolite 
excretion by growing swine. Journal of Animal Science, 90, 282–288. 
Johnson NE, Harland BF, Ross E, Gautz L and Dunn MA, 1992. Effects of dietary aluminum and 
niacin on chick tibiae. Poultry Science, 71, 1188–1195. 
Johnson NE, Qiu XL, Gautz LD and Ross E, 1995. Changes in dimensions and mechanical properties 
of bone in chicks fed high levels of niacin. Food and Chemical Toxicology, 33, 265–271. 
Knox WE and Grossman WI, 1946 A new metabolite of nicotinamide. The Journal of Biological 
Chemistry, 166, 391–392. 
Leeson S and Caston LJ, 2003. Vitamin enrichment of eggs. Journal of Applied Poultry Research, 12, 
24–26. 
Luce WG, Peo ER Jr and Hudman DB, 1966. Availability of niacin in wheat for swine. Journal of 
Nutrition, 88, 39–44. 
McDowell LR, 2000. Vitamins in animal and human nutrition, 2nd edn, Iowa State University Press, 
Ames, IA, 492. 
Mason JB, Gibson N and Kodicek E, 1971. The chemical nature of bound nicotinic acid. Biochemical 
Journal, 125, 117P–118P. 
Mason JB, Gibson N and Kodicek E, 1973. The chemical nature of the bound nicotinic acid of wheat 
bran: studies of nicotinic acid-containing macromolecules. British Journal of Nutrition, 30, 297–
311. 
Niehof  I-K,  Hüther  L  and  Lebzien  P,  2009.  Niacin  for  dairy  cattle:  a  review.  British  Journal  of 
Nutrition, 101, 5–19. 
Nilson KM, Owen FG and Georgi CE, 1967. Effect of abrupt ration change on rumen microorganisms 
and the niacin and vitamin B6 content of rumen fluid and milk. Journal of Dairy Science, 50, 1172–
1176. 
NRC  (National  Research  Council),  1987.  Vitamin  tolerance  of  animals.  The  National  Academies 
Press, Washington, DC, 47–52. 
NRC (National Research Council), 1994. Nutrient requirements of poultry. Ninth Revised Edition. 
National Academic Press, Washington, DC, 155. 
NRC (National Research Council), 1998. Nutrient requirements of swine. Tenth Revised Edition. The 
National Academies Press, Washington, DC, 189. 
NRC  (National  Research  Council),  2006.  Nutrient  requirements  of  dogs  and  cats.  The  National 
Academies Press, Washington DC, 377. 
Oduho GW and Baker DH, 1993. Quantitative efficacy of niacin sources for chicks: nicotinic acid, 
nicotinamide, NAD and tryptophan. Journal of Nutrition, 123, 2201–2206. 
OECD  (Organisation  for  Economic  Cooperation  and  Development)  SIDS,  2002.  SIDS  Initial 
Assessment  Report  for  SIAM  15,3-Pyridinecarboxamide  (nicotinamide),  CAS  No.  98-92-0. 
Available from http://www.inchem.org/documents/sids/sids/98920.pdf 
Perlzweig WA, Rosen F and Pearson PB, 1950. Comparative studies in niacin metabolism. The fate of 
niacin in man, rat, dog, pig, rabbit, guinea-pig, goat, sheep and calf. Journal of Nutrition, 40, 453–
469. 
Real DE, Nelssen JL, Unruh JA, Tokach MD, Goodband RD, Dritz SS, DeRouchey JM and Alonso E, 
2002. Effects of increasing dietary niacin on growth performance and meat quality in finishing pigs 
reared in two different environments. Journal of Animal Science 80, 3203–3210. 
Reddi KK and Kodicec E, 1953. Metabolism of nicotinic acid and related compounds in man and rat. 
Biochemical Journal, 53, 286–294. Nicotinic acid and nicotinamide for all animal species 
 
EFSA Journal 2012;10(7):2788  17 
Shibata K and Matsuo H, 1989a. Effect of supplementing low protein diets with the limiting amino 
acids on the excretion of N1-methylnicotinamide and its pyridones in rats. Journal of Nutrition, 
119, 896–901. 
Shibata K and Matsuo H, 1989b. Correlation between niacin equivalent intake and urinary excretion of 
its  metabolites,  N -methylnicotinamide,  N -methyl-2-pyridone-5-carboxamide,  and  N -methyl-4-
pyridone-3-carboxamide,  in  humans  consuming  a  self-selected  food.  The  American  Journal  of 
Clinical Nutrition, 50, 114–119. 
Shibata  K  and  Matsuo  H,  1990.  Effect  of  dietary  tryptophan  levels  on  the  urinary  excretion  of 
nicotinamide and its metabolites in rats fed a niacin-free diet or a constant total protein level. 
Journal of Nutrition, 120, 1191–1197. 
Shibata  K,  Kakehi  H  and  Matsuo  H,  1990.  Niacin  catabolism  in  rodents.  Journal  of  Nutritional 
Science and Vitaminology (Tokyo), 36, 87–98. 
USDA  National  Nutrient  Database  for  Standard  Reference,  Release  17.  Niacin  (mg)  Content  of 
Selected  Foods  per  Common  Measure,  sorted  alphabetically.  Available  from 
http://www.nal.usda.gov/fnic/foodcomp/Data/SR21/nutrlist/sr21w406.pdf 
Wagner K, Mockel P, Lebzien P and Flachowsky G, 1997. Influence of duodenal infusion of nicotinic 
acid on the milk fat composition of dairy cows. Archives of Animal Nutrition, 50, 239–244. 
Waldroup PW, Hellwig HM, Spencer GK, Smith NK, Fancher BI, Jackson ME, Johnson ZB and 
Goodwin TL, 1985. The effects of increased levels of niacin supplementation on growth rate and 
carcass composition of broiler chickens. Poultry Science, 64, 1777–1784. 
Whittemore CT, Close WH and Hazzledine MJ, 2002. The need for nutrient requirement standards for 
pigs. A report of the British Society of Animal Science nutritional standards working group: pigs. 
Pig News and Information, 23, 67N–74N. 
Yen JT, Jensen AH and Baker DH, 1977. Assessment of the Availability of Niacin in Corn, Soybeans 
and Soybean Meal. Journal of Animal Science, 45, 269–278. 
Yen JT, Lauxen R and Veum TL, 1978. Effect of supplemental niacin on ﬁnishing pigs fed soybean 
meal supplemented diets. Journal of Animal Science, 47(Suppl. 1), 325 (Abstract). Nicotinic acid and nicotinamide for all animal species 
 
EFSA Journal 2012;10(7):2788  18 
APPENDIX  
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed  Additives  on  the  Method(s)  of  Analysis  for  Niacin  (Nicotinic  acid)  and  Niacinamide 
(Nicotinamide)
33 
In the current application authorisation is sought under article 4(1)
1,2 (new use in water) and 10(2)
1-5  
for Niacin (Nicotinic acid) and Niacinamide (Nicotinamide) under the category/functional group 3(a) 
"nutritional additives"/"vitamins, pro-vitamins and chemically well defined substances having similar 
effect",  according  to  the  classification  system  of  Annex  I  of  Regulation  (EC)  No  1831/2003. 
Authorisation is sought for the use of the feed additive for all animal species and categories.  
According to the Applicants the products are white granular crystals or crystalline powder, containing 
a minimum of 99
3 % Niacin and a minimum of 98.5
3 % Niacinamide. The feed additive is intended to 
be processed in premixtures or added directly into feedingstuffs or in water. However, the Applicants 
did not specify any maximum or minimum concentration of Niacin and Niacinamide in feedingstuffs 
or water, as set in the previous regulations. 
For the determination of Niacin and Niacinamide in the feed additive, the Applicants propose various 
methods  including  the  internationally  recognised  European  Pharmacopoeia  methods  (Ph.  Eur.  6
th 
Edition, monograph 0459 for the determination of Niacin and monograph 0047 for the determination 
of Niacinamide). Even though no performance characteristics are provided, the EURL recommends 
for official control the European Pharmacopoeia methods to determine Niacin and Niacinamide in the 
feed additive. 
For the determination of Niacin and Niacinamide in premixtures, the Applicants propose two methods 
based on ion-pair Reversed Phase High Performance Liquid Chromatography coupled to UV detector 
(RP-HPLC-UV), namely (1) the method developed by VDLUFA (Association of German Agricultural 
Analytical and Research Institutes) and (2) a single-laboratory validated and further verified method 
submitted by one of the Applicants. The VDLUFA method was ring-trial validated with a Niacin and 
Niacinamide  content ranging from  3665 to 15540 mg/kg premixtures. The following performance 
characteristics  were  reported  for  Niacin  and  Niacinamide:  (i)  a  relative  standard  deviation  for 
repeatability  (RSDr)  ranging  from  3.49  to  7.58  %,  and  (ii)  a  relative  standard  deviation  for 
reproducibility (RSDR) ranging from 4.02 to 15.4 %.  
The above mentioned single-laboratory validated and further verified method is also suitable for the 
determination Niacin and Niacinamide in feedingstuffs. The performance characteristics of this method 
were recalculated by the EURL using the experimental data provided by the Applicant, to obtain: 
* For premixtures samples with contents ranging from 0.4 to 40 g/kg, for Niacin and Niacinamide: 
  RSDr ranging from 0.5 to 0.8 %; 
  RSDip (intermediate precision) ranging from 4.9 to 6.7 %; 
  RRec (recovery rate) ranging from 96.9 to 106.1 %, and 
* For feedingstuffs samples with contents ranging from 8 to 800 mg/kg: 
  RSDr ranging from 4.1 to 5.4 %; 
  RSDip ranging from 4.1 to 11.1 %; 
  RRec ranging from 95.7 to 107.0 %, and 
                                                       
33 The full report is available on the EURL website. http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
NiacineGroup.pdf 
1 FAD-2010-0112; 
2 FAD-2010-0263; 
3 FAD-2010-0198; 
4 FAD-2010-0265; 
5 FAD-2010-0397 Nicotinic acid and nicotinamide for all animal species 
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  LOD and LOQ of 2 and 8 mg/kg, respectively. 
For the determination of Niacin and Niacinamide in water the Applicant provided data, upon request 
of  the  EURL,  proving  that  the  method  for  premixtures  and  feedingstuffs  is  also  applicable  when 
analysing Niacin and Niacinamide in water, without any sample preparation except a simple dilution. 
Based  on  the  above  considerations  and  the  performance  characteristics  presented,  the  EURL 
recommends for official control the single-laboratory validated and further verified method submitted 
by  the  Applicant,  based  on  ion-pair  Reversed  Phase  High  Performance  Liquid  Chromatography 
coupled  to  UV  detector  (RP-HPLC-UV),  to  determine  Niacin  and  Niacinamide  in  premixtures, 
feedingstuffs  and  water,  within  the  concentration  range  covered  by  the  experimental  data. 
Additionally, the EURL recommends for official control the VDLUFA (Method Bd. III, 13.9.1) using 
RP-HPLC-UV, to determine Niacin and Niacinamide in premixtures. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 